1. Home
  2. JF vs LEXX Comparison

JF vs LEXX Comparison

Compare JF & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JF

J and Friends Holdings Limited American Depositary Shares

N/A

Current Price

$0.86

Market Cap

19.1M

Sector

N/A

ML Signal

N/A

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.54

Market Cap

16.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JF
LEXX
Founded
2012
2004
Country
China
Canada
Employees
30
7
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
16.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JF
LEXX
Price
$0.86
$0.54
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
8.3K
64.5K
Earning Date
04-24-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$0.46
52 Week High
$1.19
$1.55

Technical Indicators

Market Signals
Indicator
JF
LEXX
Relative Strength Index (RSI) 35.44 45.48
Support Level N/A $0.46
Resistance Level $1.02 $0.70
Average True Range (ATR) 0.05 0.05
MACD -0.01 -0.00
Stochastic Oscillator 8.15 18.50

Price Performance

Historical Comparison
JF
LEXX

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: